Gilead says its twice-yearly shot cut HIV infections by 96% in trial
In this article, Gilead announced that its twice-yearly shot reduced HIV infections by 96% in a second large study. The…
In this article, Gilead announced that its twice-yearly shot reduced HIV infections by 96% in a second large study. The…
Cancer has a profound impact on individuals, affecting their physical, emotional, and financial well-being. This burden extends to their families,…
Oura introduced its latest smart ring, the Oura Ring 4, on Thursday, priced at $349. The ring is designed to…
In this article, the Food and Drug Administration approved Bristol Myers Squibb’s new schizophrenia drug Cobenfy, marking the first innovative…
In this article, the roughly $1,000 monthly cost of Eli Lilly’s weight loss drug Zepbound has made it unaffordable for…
In this article, Delta Air Lines had to suspend hot meal service on more than 200 flights departing from its…
In this article, the U.S. surgeon general issued a new advisory warning about the connection between alcohol consumption and an…
In this article, a week after health authorities publicly linked a deadly E. coli outbreak to McDonald’s Quarter Pounder burgers,…
In this article, prescription fills for blockbuster weight loss drugs in the U.S. more than doubled in 2024, despite limited…